Tianda Pharmaceuticals Limited (00455) published its monthly securities movements for the period ended 31 October 2025. The total authorized share capital remained at 4,000,000,000 ordinary shares with a par value of HKD 0.1 per share, amounting to HKD 400,000,000. There was no change in the company’s authorized or issued share capital during the reporting month.

The number of issued shares stood at 2,150,041,884, and there were no treasury shares recorded. Under the share option scheme, there remained 215,004,188 shares that may be issued or transferred out of treasury upon exercise of options, with no share issuance or transfer activity recorded for the month.